Assessment of Anticardiolipin antibodies, Circulating Lupus anticoagulant, Protein C, Protein S, Antithrombin III &Activated Protein C Resistance and Their Relation to Thomboembolic and Other Clinical Manifestations in Behcet's Disease
Last updated: 24 Dec 2024
10.21608/ejhm.2006.17919
Procoagulant factors, anticardiolipin antibodies, Thromboembolic manifestations, Behcet’s disease
Seham M. S.
EL- Nakeeb
Biochemistry Faculty of Medicine AL–Azhar University
Ahmed M.
Ragheb
Clinical Pathology Faculty of Medicine AL–Azhar University
H.S.
El -Baz
Clinical Pathology Faculty of Medicine AL–Azhar University
Abdel ShafyA.
H
Rheumatology and Rehabilitation Dept. Faculty of Medicine AL–Azhar University
A.M.
Salama
Chest Dept. Faculty of Medicine for Girls. AL–Azhar University
Zeinab A.
Zakzouk
Chest Dept. Faculty of Medicine for Girls. AL–Azhar University
24
1
3737
2006-07-01
2018-10-30
2006-07-01
539
547
1687-2002
2090-7125
https://ejhm.journals.ekb.eg/article_17919.html
https://ejhm.journals.ekb.eg/service?article_code=17919
11
Original Article
606
Journal
The Egyptian Journal of Hospital Medicine
https://ejhm.journals.ekb.eg/
Assessment of Anticardiolipin antibodies, Circulating Lupus anticoagulant, Protein C, Protein S, Antithrombin III &Activated Protein C Resistance and Their Relation to Thomboembolic and Other Clinical Manifestations in Behcet's Disease
Details
Type
Article
Created At
22 Jan 2023